Gurpreet Kaur

Dr. Gurpreet Kaur


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2015 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
DMDeepinder Singh Malik
Deepinder Singh Malik
NMN. Mittal
N. Mittal
GKGurpreet Kaur
Gurpreet Kaur
Introduction: Topical administration is the favored route for local delivery of therapeutic agents due to its convenience and affordability. The specific challenge of designing a therapeutic system...

1 January 2012 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
AKAmanpreet Kaur
Amanpreet Kaur
GKGurpreet Kaur
Gurpreet Kaur
The study was designed to develop bioadhesive patches of carvedilol hydrochloride using chitosan (CH) and pectin (PE) interpolymer complexes and to systematically evaluate their in vitro and in vivo performances. Mucoadhesive buccal patches of carvedilol were prepared using solvent casting method. The physicochemical interaction between CH and PE was investigated by FTIR and DSC studies. The patches were evaluated for their physical characteristics like mass variation, content uniformity, folding endurance, ex vivo mucoadhesion strength, ex vivo mucoadhesion time, surface pH, in vitro drug release, in situ release study, and in vivo bioavailability study. The swelling index of the patches was found to be proportional to the PE concentration. The surface pH of all the formulated bioadhesive patches was found to lie between 6.2 and 7.2. The optimized bioadhesive patch (C1, CH:PE 20:80) showed bioadhesive strength of 22.10 ± 0.20 g, in vitro release of 98.73% and ex vivo mucoadhesion time of 451 min with in a period of 8 h. The optimized patch demonstrated good in vitro and in vivo results. The buccal delivery of carvedilol in rabbits showed a significant improvement in bioavailability of carvedilol from patches when compared to oral route.

3 March 2014 in Journal of Pharmaceutics
Verified
Journal Article
Open access
PDF file
HKHarkiran Kaur
Harkiran Kaur
GKGurpreet Kaur
Gurpreet Kaur
Polyphenols constitute a family of natural substances distributed widely in plant kingdom. These are produced as secondary metabolites by plants and so far 8000 representatives of this family have been identified. Recently, there is an increased interest in the polyphenols because of the evidence of their role in prevention of degenerative diseases such as neurodegenerative diseases, cancer, and cardiovascular diseases. Although a large number of drugs are available in the market for treatment of these diseases, however, the emphasis these days is on the exploitation of natural principles derived from plants. Most polyphenols show lowin vivobioavailability thus limiting their application for oral drug delivery. This low bioavailability could be associated with low aqueous solubility, first pass effect, metabolism in GIT, or irreversible binding to cellular DNA and proteins. Therefore, there is a need to devise strategies to improve oral bioavailability of polyphenols. Various approaches like nanosizing, self-microemulsifying drug delivery systems (SMEDDS), microencapsulation, complexation, and solid dispersion can be used to increase the bioavailability. This paper will highlight the various methods that have been employed till date for the solubility enhancement of various polyphenols so that a suitable drug delivery system can be formulated.

1 September 2014 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
GKGurpreet Kaur
Gurpreet Kaur
DSDeepinder Singh
Deepinder Singh
VBVivekjot Brar
Vivekjot Brar

1 March 2015 in Journal of Functional Foods
Verified
Journal Article
Closed access
JKJasleen Kaur
Jasleen Kaur
GKGurpreet Kaur
Gurpreet Kaur

22 August 2018 in Polymers for Advanced Technologies
Verified
Journal Article
Closed access
PDF file
JKJasleen Kaur
Jasleen Kaur
GKGurpreet Kaur
Gurpreet Kaur